ArticleOncotarget2017

Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis.

Ling Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.